ArticleFrontiers in oncology2024

Clinical utility of circulating tumor DNA profiling in detecting targetable fusions in non-small cell lung cancer.

Young-Gon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.